Header Logo

Connection

Ira Targoff to Humans

This is a "connection" page, showing publications Ira Targoff has written about Humans.
Connection Strength

0.736
  1. SDS-PAGE for 35S Immunoprecipitation and Immunoprecipitation Western Blotting. Methods Mol Biol. 2019; 1855:417-436.
    View in: PubMed
    Score: 0.036
  2. Immunoprecipitation: Western blot for proteins of low abundance. Methods Mol Biol. 2015; 1312:327-42.
    View in: PubMed
    Score: 0.028
  3. SDS-PAGE for ³5S immunoprecipitation and immunoprecipitation western blotting. Methods Mol Biol. 2012; 869:215-33.
    View in: PubMed
    Score: 0.022
  4. Immunoprecipitation-western blot for proteins of low abundance. Methods Mol Biol. 2009; 536:259-75.
    View in: PubMed
    Score: 0.018
  5. Autoantibodies and their significance in myositis. Curr Rheumatol Rep. 2008 Aug; 10(4):333-40.
    View in: PubMed
    Score: 0.018
  6. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum. 2007 Apr; 56(4):1295-303.
    View in: PubMed
    Score: 0.016
  7. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006 Nov; 54(11):3682-9.
    View in: PubMed
    Score: 0.016
  8. Myositis specific autoantibodies. Curr Rheumatol Rep. 2006 Jun; 8(3):196-203.
    View in: PubMed
    Score: 0.015
  9. Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features. Rheumatology (Oxford). 2023 02 23; 62(SI2):SI226-SI234.
    View in: PubMed
    Score: 0.012
  10. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2002 Nov; 28(4):859-90, viii.
    View in: PubMed
    Score: 0.012
  11. Idiopathic inflammatory myopathy: autoantibody update. Curr Rheumatol Rep. 2002 Oct; 4(5):434-41.
    View in: PubMed
    Score: 0.012
  12. Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies. Ann Rheum Dis. 2023 Feb; 82(2):235-245.
    View in: PubMed
    Score: 0.012
  13. Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis. Rheumatology (Oxford). 2022 07 06; 61(7):2969-2977.
    View in: PubMed
    Score: 0.012
  14. Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes. Pediatr Rheumatol Online J. 2022 Apr 12; 20(1):28.
    View in: PubMed
    Score: 0.011
  15. Corticosteroid discontinuation, complete clinical response and remission in juvenile dermatomyositis. Rheumatology (Oxford). 2021 05 14; 60(5):2134-2145.
    View in: PubMed
    Score: 0.011
  16. Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America. Rheumatology (Oxford). 2021 04 06; 60(4):1839-1849.
    View in: PubMed
    Score: 0.011
  17. Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol. 2000 Nov; 12(6):475-81.
    View in: PubMed
    Score: 0.010
  18. Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies. RMD Open. 2020 09; 6(2).
    View in: PubMed
    Score: 0.010
  19. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies. Arthritis Res Ther. 2020 04 06; 22(1):69.
    View in: PubMed
    Score: 0.010
  20. Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients. Arthritis Res Ther. 2020 01 08; 22(1):5.
    View in: PubMed
    Score: 0.010
  21. Long-term outcomes in Juvenile Myositis patients. Semin Arthritis Rheum. 2020 02; 50(1):149-155.
    View in: PubMed
    Score: 0.009
  22. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2019 07; 78(7):988-995.
    View in: PubMed
    Score: 0.009
  23. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies. J Autoimmun. 1999 Mar; 12(2):137-42.
    View in: PubMed
    Score: 0.009
  24. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol. 1999 Feb 15; 162(4):2315-20.
    View in: PubMed
    Score: 0.009
  25. Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis. Rheumatology (Oxford). 2018 11 01; 57(11):1956-1963.
    View in: PubMed
    Score: 0.009
  26. Medications received by patients with juvenile dermatomyositis. Semin Arthritis Rheum. 2018 12; 48(3):513-522.
    View in: PubMed
    Score: 0.009
  27. The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis. Semin Arthritis Rheum. 2018 12; 48(3):504-512.
    View in: PubMed
    Score: 0.009
  28. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2018 05; 77(5):714-719.
    View in: PubMed
    Score: 0.009
  29. Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol. 1997 Nov; 9(6):527-35.
    View in: PubMed
    Score: 0.008
  30. Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review. Scand J Rheumatol. 2018 05; 47(3):210-224.
    View in: PubMed
    Score: 0.008
  31. Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients. Arthritis Care Res (Hoboken). 2017 07; 69(7):1088-1094.
    View in: PubMed
    Score: 0.008
  32. Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype. Medicine (Baltimore). 2017 Jan; 96(3):e5694.
    View in: PubMed
    Score: 0.008
  33. Monitoring change in volume of calcifications in juvenile idiopathic inflammatory myopathy: a pilot study using low dose computed tomography. Pediatr Rheumatol Online J. 2016 Nov 29; 14(1):64.
    View in: PubMed
    Score: 0.008
  34. Epitope analysis of the major reactive region of the 100-kd protein of PM-Scl autoantigen. Arthritis Rheum. 1996 Sep; 39(9):1588-95.
    View in: PubMed
    Score: 0.008
  35. Brief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis. Arthritis Rheumatol. 2016 Mar; 68(3):761-8.
    View in: PubMed
    Score: 0.007
  36. Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. J Clin Invest. 1995 Oct; 96(4):1730-7.
    View in: PubMed
    Score: 0.007
  37. Autoantibodies in sera from patients with L-tryptophan-associated eosinophilia-myalgia syndrome. Demonstration of unique antigen-antibody specificities. Clin Immunol Immunopathol. 1995 Aug; 76(2):115-9.
    View in: PubMed
    Score: 0.007
  38. Analysis of the Mi-2 autoantigen of dermatomyositis. Arthritis Rheum. 1995 Jan; 38(1):123-8.
    View in: PubMed
    Score: 0.007
  39. Primary structure and functional expression of human Glycyl-tRNA synthetase, an autoantigen in myositis. J Biol Chem. 1994 Nov 18; 269(46):28790-7.
    View in: PubMed
    Score: 0.007
  40. Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am. 1994 Nov; 20(4):857-80.
    View in: PubMed
    Score: 0.007
  41. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Medicine (Baltimore). 2014 Nov; 93(24):318-332.
    View in: PubMed
    Score: 0.007
  42. An autoimmune myositis-overlap syndrome associated with autoantibodies to nuclear pore complexes: description and long-term follow-up of the anti-Nup syndrome. Medicine (Baltimore). 2014 Nov; 93(24):383-394.
    View in: PubMed
    Score: 0.007
  43. Analysis of the specificity of anti-PM-Scl autoantibodies. Arthritis Rheum. 1994 Oct; 37(10):1445-52.
    View in: PubMed
    Score: 0.007
  44. Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken). 2014 May; 66(5):732-40.
    View in: PubMed
    Score: 0.007
  45. Prolidase deficiency breaks tolerance to lupus-associated antigens. Int J Rheum Dis. 2013 Dec; 16(6):674-80.
    View in: PubMed
    Score: 0.006
  46. Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophy. Arthritis Care Res (Hoboken). 2013 Dec; 65(12):1969-75.
    View in: PubMed
    Score: 0.006
  47. Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis. Arthritis Rheum. 2013 Jul; 65(7):1934-41.
    View in: PubMed
    Score: 0.006
  48. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013 Jul; 92(4):223-243.
    View in: PubMed
    Score: 0.006
  49. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J Clin Invest. 1993 Jun; 91(6):2556-64.
    View in: PubMed
    Score: 0.006
  50. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013 Jan; 92(1):25-41.
    View in: PubMed
    Score: 0.006
  51. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol. 1993 Jan; 100(1):116S-123S.
    View in: PubMed
    Score: 0.006
  52. Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen. J Clin Invest. 1992 Aug; 90(2):559-70.
    View in: PubMed
    Score: 0.006
  53. Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum. 1992 Jul; 35(7):821-30.
    View in: PubMed
    Score: 0.006
  54. Autoantibodies in polymyositis. Rheum Dis Clin North Am. 1992 May; 18(2):455-82.
    View in: PubMed
    Score: 0.006
  55. Antinuclear antibodies: clinical correlations and biologic significance. Adv Dermatol. 1992; 7:3-52; discussion 53.
    View in: PubMed
    Score: 0.006
  56. Polymyositis. Immunol Ser. 1991; 54:201-46.
    View in: PubMed
    Score: 0.005
  57. Immune mechanisms in myositis. Curr Opin Rheumatol. 1990 Dec; 2(6):882-8.
    View in: PubMed
    Score: 0.005
  58. Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review. Int J Cardiol. 2011 May 05; 148(3):261-70.
    View in: PubMed
    Score: 0.005
  59. Antibody to signal recognition particle in polymyositis. Arthritis Rheum. 1990 Sep; 33(9):1361-70.
    View in: PubMed
    Score: 0.005
  60. Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford). 2010 Dec; 49(12):2381-90.
    View in: PubMed
    Score: 0.005
  61. Diagnosis and treatment of polymyositis and dermatomyositis. Compr Ther. 1990 Apr; 16(4):16-24.
    View in: PubMed
    Score: 0.005
  62. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med. 1990 Mar; 88(3):241-51.
    View in: PubMed
    Score: 0.005
  63. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J Immunol. 1990 Mar 01; 144(5):1737-43.
    View in: PubMed
    Score: 0.005
  64. Immunologic aspects of myositis. Curr Opin Rheumatol. 1989 Dec; 1(4):432-42.
    View in: PubMed
    Score: 0.005
  65. Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. Clin Immunol. 2009 Dec; 133(3):353-63.
    View in: PubMed
    Score: 0.005
  66. Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheum. 2009 Aug; 60(8):2499-504.
    View in: PubMed
    Score: 0.005
  67. Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease. J Clin Invest. 1989 Jul; 84(1):162-72.
    View in: PubMed
    Score: 0.005
  68. Humoral immunity in polymyositis and dermatomyositis. Mt Sinai J Med. 1988 Nov; 55(6):487-93.
    View in: PubMed
    Score: 0.004
  69. Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies. Arthritis Rheum. 2008 Oct; 58(10):3239-46.
    View in: PubMed
    Score: 0.004
  70. Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum. 1988 Apr; 31(4):515-24.
    View in: PubMed
    Score: 0.004
  71. Laboratory manifestations of polymyositis/dermatomyositis. Clin Dermatol. 1988 Apr-Jun; 6(2):76-92.
    View in: PubMed
    Score: 0.004
  72. Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine (Baltimore). 2008 Mar; 87(2):70-86.
    View in: PubMed
    Score: 0.004
  73. Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures. Arthritis Rheum. 2007 Aug; 56(8):2719-28.
    View in: PubMed
    Score: 0.004
  74. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity. J Immunol. 1987 May 01; 138(9):2874-82.
    View in: PubMed
    Score: 0.004
  75. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther. 2007; 9(4):R78.
    View in: PubMed
    Score: 0.004
  76. HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum. 2006 Nov; 54(11):3670-81.
    View in: PubMed
    Score: 0.004
  77. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore). 2006 Mar; 85(2):111-127.
    View in: PubMed
    Score: 0.004
  78. Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups. Arthritis Rheum. 2005 Aug; 52(8):2433-8.
    View in: PubMed
    Score: 0.004
  79. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore). 2005 Jul; 84(4):231-249.
    View in: PubMed
    Score: 0.004
  80. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum. 1985 Jul; 28(7):796-803.
    View in: PubMed
    Score: 0.004
  81. Nucleolar localization of the PM-Scl antigen. Arthritis Rheum. 1985 Feb; 28(2):226-30.
    View in: PubMed
    Score: 0.003
  82. Immunogenetic differences between Caucasian women with and those without silicone implants in whom myositis develops. Arthritis Rheum. 2004 Nov; 50(11):3646-50.
    View in: PubMed
    Score: 0.003
  83. Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum. 2003 Aug; 48(8):2285-93.
    View in: PubMed
    Score: 0.003
  84. Antibodies to Mi-1 in SLE: relationship to other precipitins and reaction with bovine immunoglobulin. Clin Exp Immunol. 1983 Jul; 53(1):76-82.
    View in: PubMed
    Score: 0.003
  85. Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis. Arthritis Rheum. 2002 Jul; 46(7):1885-93.
    View in: PubMed
    Score: 0.003
  86. Antiendothelial cell antibodies in inflammatory myopathies: distribution among clinical and serologic groups and association with interstitial lung disease. J Rheumatol. 2000 Jan; 27(1):161-4.
    View in: PubMed
    Score: 0.002
  87. Characterization of an autoantigen associated with chronic ulcerative stomatitis: the CUSP autoantigen is a member of the p53 family. J Invest Dermatol. 1999 Aug; 113(2):146-51.
    View in: PubMed
    Score: 0.002
  88. Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci. Arthritis Rheum. 1999 Jun; 42(6):1285-90.
    View in: PubMed
    Score: 0.002
  89. Detection of anti-PL-12 autoantibodies by ELISA using a recombinant antigen; study of the immunoreactive region. Clin Exp Immunol. 1998 Nov; 114(2):161-5.
    View in: PubMed
    Score: 0.002
  90. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy. Arthritis Rheum. 1998 Apr; 41(4):710-9.
    View in: PubMed
    Score: 0.002
  91. Anti-endothelial cell antibody, thrombomodulin, and von Willebrand factor in idiopathic inflammatory myopathies. Clin Diagn Lab Immunol. 1997 Sep; 4(5):519-21.
    View in: PubMed
    Score: 0.002
  92. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum. 1997 Jul; 40(7):1257-66.
    View in: PubMed
    Score: 0.002
  93. Anti-U5 small nuclear ribonucleoprotein (snRNP) antibodies: a rare anti-U snRNP specificity. Clin Immunol Immunopathol. 1996 Oct; 81(1):41-7.
    View in: PubMed
    Score: 0.002
  94. Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. Arthritis Rheum. 1996 Oct; 39(10):1769-71.
    View in: PubMed
    Score: 0.002
  95. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma. J Rheumatol. 1996 Oct; 23(10):1729-33.
    View in: PubMed
    Score: 0.002
  96. Clinical significance of specific autoantibodies in juvenile dermatomyositis. J Rheumatol. 1996 Oct; 23(10):1794-7.
    View in: PubMed
    Score: 0.002
  97. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum. 1996 Sep; 39(9):1507-18.
    View in: PubMed
    Score: 0.002
  98. Assignment of two human autoantigen genes-isoleucyl-tRNA synthetase locates to 9q21 and lysyl-tRNA synthetase locates to 16q23-q24. Genomics. 1996 Aug 15; 36(1):210-3.
    View in: PubMed
    Score: 0.002
  99. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum. 1996 Aug; 26(1):459-67.
    View in: PubMed
    Score: 0.002
  100. Coexistence of two antisynthetases in a patient with the antisynthetase syndrome. Arthritis Rheum. 1996 Apr; 39(4):692-7.
    View in: PubMed
    Score: 0.002
  101. Autoantibodies to glycyl-transfer RNA synthetase in myositis. Association with dermatomyositis and immunologic heterogeneity. Arthritis Rheum. 1996 Jan; 39(1):146-51.
    View in: PubMed
    Score: 0.002
  102. Localization of two human autoantigen genes by PCR screening and in situ hybridization--glycyl-tRNA synthetase locates to 7p15 and alanyl-tRNA synthetase locates to 16q22. Genomics. 1995 Nov 01; 30(1):131-2.
    View in: PubMed
    Score: 0.002
  103. NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med. 1995 May 01; 122(9):715-24.
    View in: PubMed
    Score: 0.002
  104. Pulmonary fibrosis and myositis in a child with anti-Jo-1 antibody. J Rheumatol. 1995 Apr; 22(4):762-5.
    View in: PubMed
    Score: 0.002
  105. A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children. Arthritis Rheum. 1994 Oct; 37(10):1534-8.
    View in: PubMed
    Score: 0.002
  106. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med. 1993 Apr; 94(4):379-87.
    View in: PubMed
    Score: 0.002
  107. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore). 1991 Nov; 70(6):360-74.
    View in: PubMed
    Score: 0.001
  108. Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum. 1991 Nov; 34(11):1391-6.
    View in: PubMed
    Score: 0.001
  109. Aseptic meningitis in association with diclofenac treatment in a patient with systemic lupus erythematosus. Arthritis Rheum. 1991 Oct; 34(10):1340-1.
    View in: PubMed
    Score: 0.001
  110. Clinical, serologic, and immunogenetic studies in patients with dermatomyositis. Acta Derm Venereol. 1991; 71(4):312-6.
    View in: PubMed
    Score: 0.001
  111. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum. 1990 Aug; 33(8):1240-8.
    View in: PubMed
    Score: 0.001
  112. C4 null genes in American whites and blacks with myositis. J Rheumatol. 1990 Mar; 17(3):331-4.
    View in: PubMed
    Score: 0.001
  113. Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol. 1984 Jan; 4(1):40-4.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.